• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIF1α和HIF2α对IGF1R的协同调节增强了胶质母细胞瘤的化疗耐药性。

Coordinated regulation of IGF1R by HIF1α and HIF2α enhances chemoresistance in glioblastoma.

作者信息

Liao Bin, Wang Pan, Gong Sheng, Zhao Lu, Liu Jie, Wu Nan

机构信息

Chongqing Medical University, Chongqing, China.

Department of Neurosurgery, Chongqing Research Center for Glioma Precision Medicine, Chongqing General Hospital, Chongqing University, Chongqing, China.

出版信息

Front Pharmacol. 2025 Apr 11;16:1575332. doi: 10.3389/fphar.2025.1575332. eCollection 2025.

DOI:10.3389/fphar.2025.1575332
PMID:40290443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12021886/
Abstract

BACKGROUND

This study investigates whether Hypoxia-Inducible Factor 1 alpha (HIF1α) and Hypoxia-Inducible Factor 2 alpha (HIF2α) coordinately regulate insulin-like growth factor 1 receptor (IGF1R) expression, thereby influencing chemosensitivity in glioblastoma multiforme (GBM).

METHODS

We analyzed the expression and correlation of HIF1α, HIF2α, and IGF1R in glioma using The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) databases. Immunohistochemistry (IHC) was performed to detect the expression of HIF1α, HIF2α, and IGF1R in GBM tissues and cells, as well as oxygen tension. Cell cycle analysis, apoptosis assays, lactate dehydrogenase (LDH) release measurements, Western blotting, and xenograft tumor models were employed to explore the synergistic regulation of IGF1R by HIF1α and HIF2α, focusing on activation of the PI3K/AKT signaling pathway and its contribution to GBM drug resistance. Chromatin immunoprecipitation-quantitative PCR (ChIP-qPCR) and dual-luciferase reporter assays were used to investigate the binding sites of HIF1α and HIF2α involved in regulating IGF1R.

RESULTS

Our study demonstrated that HIF1α and HIF2α were highly expressed in GBM tissues and hypoxia-cultured cells, and their expression positively correlated with IGF1R expression. Simultaneous knockout of HIF1α and HIF2α in GBM cells resulted in the highest LDH release and apoptosis rates under hypoxic conditions, accompanied by the most significant decrease in IGF1R, p-PDK1, and p-AKT levels. Knockout of IGF1R in tumor cells under hypoxia led to an increas of LDH release and apoptosis rates, and reduced phosphorylation of PDK1 and AKT. In addition, we demonstrated that HIF1α and HIF2α promoted IGF1R expression by binding to a specific hypoxia response element (HRE) sequence (5'-GAACGTGCCT-3') within the IGF1R promoter using dual-luciferase reporter system.

CONCLUSION

Glioblastoma cells, residing within a hypoxic microenvironment, exhibit high expression of HIF1α and HIF2α. These transcription factors promote the upregulation of IGF1R, which subsequently activates the PI3K/AKT signaling pathway. This activation, in turn, promotes cell proliferation and chemoresistance, ultimately contributing to tumor malignancy.

摘要

背景

本研究调查缺氧诱导因子1α(HIF1α)和缺氧诱导因子2α(HIF2α)是否协同调节胰岛素样生长因子1受体(IGF1R)的表达,从而影响多形性胶质母细胞瘤(GBM)的化疗敏感性。

方法

我们使用癌症基因组图谱(TCGA)和中国胶质瘤基因组图谱(CGGA)数据库分析了胶质瘤中HIF1α、HIF2α和IGF1R的表达及相关性。进行免疫组织化学(IHC)检测GBM组织和细胞中HIF1α、HIF2α和IGF1R的表达以及氧张力。采用细胞周期分析、凋亡检测、乳酸脱氢酶(LDH)释放测定、蛋白质免疫印迹法和异种移植肿瘤模型,探讨HIF1α和HIF2α对IGF1R的协同调节作用,重点关注PI3K/AKT信号通路的激活及其对GBM耐药性的影响。采用染色质免疫沉淀-定量聚合酶链反应(ChIP-qPCR)和双荧光素酶报告基因检测法研究HIF1α和HIF2α参与调节IGF1R的结合位点。

结果

我们的研究表明,HIF1α和HIF2α在GBM组织和缺氧培养的细胞中高表达,它们的表达与IGF1R表达呈正相关。在GBM细胞中同时敲除HIF1α和HIF2α导致缺氧条件下LDH释放率和凋亡率最高,同时IGF1R、p-PDK1和p-AKT水平显著降低。缺氧条件下肿瘤细胞中IGF1R的敲除导致LDH释放率和凋亡率增加,PDK1和AKT的磷酸化减少。此外,我们使用双荧光素酶报告系统证明,HIF1α和HIF2α通过与IGF1R启动子内的特定缺氧反应元件(HRE)序列(5'-GAACGTGCCT-3')结合来促进IGF1R的表达。

结论

存在于缺氧微环境中的胶质母细胞瘤细胞表现出HIF1α和HIF2α的高表达。这些转录因子促进IGF1R的上调,随后激活PI3K/AKT信号通路。这种激活反过来促进细胞增殖和化疗耐药性,最终导致肿瘤恶性进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a6/12021886/940931f8c16f/fphar-16-1575332-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a6/12021886/a7f8b058524b/fphar-16-1575332-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a6/12021886/4c708428b71c/fphar-16-1575332-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a6/12021886/6fe5f5d87a3d/fphar-16-1575332-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a6/12021886/3d3cfcec5fa2/fphar-16-1575332-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a6/12021886/940931f8c16f/fphar-16-1575332-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a6/12021886/a7f8b058524b/fphar-16-1575332-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a6/12021886/4c708428b71c/fphar-16-1575332-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a6/12021886/6fe5f5d87a3d/fphar-16-1575332-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a6/12021886/3d3cfcec5fa2/fphar-16-1575332-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a6/12021886/940931f8c16f/fphar-16-1575332-g005.jpg

相似文献

1
Coordinated regulation of IGF1R by HIF1α and HIF2α enhances chemoresistance in glioblastoma.HIF1α和HIF2α对IGF1R的协同调节增强了胶质母细胞瘤的化疗耐药性。
Front Pharmacol. 2025 Apr 11;16:1575332. doi: 10.3389/fphar.2025.1575332. eCollection 2025.
2
HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia.低氧诱导因子 1α/2α- Sox2-Klf4 通过正反馈促进胶质母细胞瘤的恶性进展,其作用途径是缺氧下的表皮生长因子受体-磷酸肌醇 3-激酶/蛋白激酶 B 信号通路。
Cell Death Dis. 2021 Mar 24;12(4):312. doi: 10.1038/s41419-021-03598-8.
3
The HIF1α/HIF2α-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions.缺氧条件下 HIF1α/HIF2α-miR210-3p 网络通过 EGF 调节脑胶质瘤细胞的增殖、去分化和化疗耐药性。
Cell Death Dis. 2020 Nov 18;11(11):992. doi: 10.1038/s41419-020-03150-0.
4
HIF1α/HIF2α induces glioma cell dedifferentiation into cancer stem cells through Sox2 under hypoxic conditions.在缺氧条件下,HIF1α/HIF2α通过Sox2诱导胶质瘤细胞去分化为癌干细胞。
J Cancer. 2022 Jan 1;13(1):1-14. doi: 10.7150/jca.54402. eCollection 2022.
5
Long non-coding RNA lung cancer-associated transcript-1 promotes glioblastoma progression by enhancing Hypoxia-inducible factor 1 alpha activity.长链非编码 RNA 肺癌相关转录本-1 通过增强低氧诱导因子 1α活性促进胶质母细胞瘤进展。
Neuro Oncol. 2024 Aug 5;26(8):1388-1401. doi: 10.1093/neuonc/noae036.
6
Temozolomide promotes glioblastoma stemness expression through senescence-associated reprogramming via HIF1α/HIF2α regulation.替莫唑胺通过HIF1α/HIF2α调控的衰老相关重编程促进胶质母细胞瘤干性表达。
Cell Death Dis. 2025 Apr 19;16(1):317. doi: 10.1038/s41419-025-07617-w.
7
Hyperbaric oxygen promotes not only glioblastoma proliferation but also chemosensitization by inhibiting HIF1α/HIF2α-Sox2.高压氧不仅通过抑制HIF1α/HIF2α-Sox2促进胶质母细胞瘤增殖,还能促进其化学增敏作用。
Cell Death Discov. 2021 May 13;7(1):103. doi: 10.1038/s41420-021-00486-0.
8
The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin.HIF1α-PDGFD-PDGFRα 轴在常氧/轻度低氧条件下控制胶质母细胞瘤的生长,并赋予依西美坦对靶向治疗的敏感性。
J Exp Clin Cancer Res. 2021 Sep 1;40(1):278. doi: 10.1186/s13046-021-02082-7.
9
HIF1α and HIF2α regulate non-small-cell lung cancer dedifferentiation via expression of Sox2 and Oct4 under hypoxic conditions.在缺氧条件下,低氧诱导因子1α(HIF1α)和低氧诱导因子2α(HIF2α)通过Sox2和Oct4的表达来调控非小细胞肺癌的去分化。
Gene. 2023 May 5;863:147288. doi: 10.1016/j.gene.2023.147288. Epub 2023 Feb 16.
10
Roles of HIF1α- and HIF2α-regulated BNIP3 in hypoxia-induced injury of neurons.低氧诱导因子1α(HIF1α)和低氧诱导因子2α(HIF2α)调控的BNIP3在神经元低氧诱导损伤中的作用
Pathol Res Pract. 2019 Apr;215(4):822-827. doi: 10.1016/j.prp.2019.01.022. Epub 2019 Jan 18.

本文引用的文献

1
Review of Novel Surgical, Radiation, and Systemic Therapies and Clinical Trials in Glioblastoma.胶质母细胞瘤的新型手术、放疗和系统治疗及临床试验述评。
Int J Mol Sci. 2024 Sep 30;25(19):10570. doi: 10.3390/ijms251910570.
2
Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme.克服胶质母细胞瘤缺氧的临床前和临床进展。
Cell Death Dis. 2024 Jul 13;15(7):503. doi: 10.1038/s41419-024-06904-2.
3
p52-ZER6/IGF1R axis maintains cancer stem cell population to promote cancer progression by enhancing pro-survival mitophagy.
p52-ZER6/IGF1R轴通过增强促生存线粒体自噬维持癌症干细胞群体,以促进癌症进展。
Oncogene. 2024 Jun;43(27):2115-2131. doi: 10.1038/s41388-024-03058-5. Epub 2024 May 21.
4
Glioma.胶质瘤。
Nat Rev Dis Primers. 2024 May 9;10(1):33. doi: 10.1038/s41572-024-00516-y.
5
Prognosis and therapeutic significance of IGF-1R-related signaling pathway gene signature in glioma.IGF-1R相关信号通路基因特征在胶质瘤中的预后及治疗意义
Front Cell Dev Biol. 2024 Apr 11;12:1375030. doi: 10.3389/fcell.2024.1375030. eCollection 2024.
6
Integrative spatial analysis reveals a multi-layered organization of glioblastoma.整合空间分析揭示胶质母细胞瘤的多层次组织。
Cell. 2024 May 9;187(10):2485-2501.e26. doi: 10.1016/j.cell.2024.03.029. Epub 2024 Apr 22.
7
The HIFIA/LINC02913/IGF1R axis promotes the cell function of adipose-derived mesenchymal stem cells under hypoxia via activating the PI3K/AKT pathway.HIFIA/LINC02913/IGF1R 轴通过激活 PI3K/AKT 通路促进低氧环境下脂肪间充质干细胞的细胞功能。
J Transl Med. 2023 Oct 17;21(1):732. doi: 10.1186/s12967-023-04581-x.
8
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.美国 2016-2020 年诊断的原发性脑和其他中枢神经系统肿瘤 CBTRUS 统计报告。
Neuro Oncol. 2023 Oct 4;25(12 Suppl 2):iv1-iv99. doi: 10.1093/neuonc/noad149.
9
Drugging IGF-1R in cancer: New insights and emerging opportunities.癌症中靶向胰岛素样生长因子-1受体(IGF-1R):新见解与新机遇
Genes Dis. 2022 Mar 23;10(1):199-211. doi: 10.1016/j.gendis.2022.03.002. eCollection 2023 Jan.
10
Tumor microenvironment in glioblastoma: Current and emerging concepts.胶质母细胞瘤中的肿瘤微环境:当前及新出现的概念
Neurooncol Adv. 2023 Feb 23;5(1):vdad009. doi: 10.1093/noajnl/vdad009. eCollection 2023 Jan-Dec.